<DOC>
	<DOCNO>NCT01217606</DOCNO>
	<brief_summary>This study evaluate safety efficacy Triple Combination Therapy compare Fixed Combination brimonidine tartrate/timolol ophthalmic solution patient primary open-angle glaucoma ocular hypertension .</brief_summary>
	<brief_title>Safety Efficacy Triple Combination Therapy Patients With Primary Open-Angle Glaucoma Ocular Hypertension</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<mesh_term>Glaucoma</mesh_term>
	<mesh_term>Ocular Hypertension</mesh_term>
	<mesh_term>Glaucoma , Open-Angle</mesh_term>
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<mesh_term>Bimatoprost</mesh_term>
	<mesh_term>Brimonidine Tartrate</mesh_term>
	<mesh_term>Timolol</mesh_term>
	<mesh_term>Brimonidine Tartrate , Timolol Maleate Drug Combination</mesh_term>
	<mesh_term>Ophthalmic Solutions</mesh_term>
	<criteria>Ocular hypertension primary openangle glaucoma eye Requires treatment IOPlowering medication eye Required chronic use ocular medication study study medication Use corticosteroid within 30 day History traumatic eye surgery Cataract surgery past 6 month Anticipated wear contact lens study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>